11:50 AM, 29th Jun 2024
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 and in continuation to our letter dated 4th May 2024 regarding the execution of definitive agreement to acquire the remaining 24% of the equity share capital ie. 27083884 equity shares of face value of Rs.10 each of DR Axion India Private Limited a Material Subsidiary of the Company we wish to inform you that the Company has completed the acquisition of the 24% of the equity stake in DR Axion India Private Limited on 29th June 2024.